Anatomy Based Selection of CI Array for SSD Patients
Anatomy-Based Cochlear Implant Array Selection for Patients With Single-Sided Deafness
1 other identifier
interventional
10
0 countries
N/A
Brief Summary
The purpose of the study is to evaluate cochlear implant speech outcomes and subjective benefit for cochlear implant recipients with single-sided deafness using patient-specific, anatomy-based array selection versus standard of care with a fixed array size for all patients. Subjects will prospectively be assigned to receive an Anatomy-Based Electrode (FLEX26, FLEX28, or FLEXSOFT) or the Standard of Care Electrode array (FLEX28). Speech performance and subjective benefit will be evaluated between these two groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2023
CompletedFirst Posted
Study publicly available on registry
January 3, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 3, 2024
December 1, 2023
1.5 years
December 18, 2023
December 18, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Speech perception in spatially separated noise
Change in percent correct on the AzBio sentences in noise, with speech presented to the front and noise to the better hearing ear
6 months post activation
Secondary Outcomes (4)
Speech perception in noise
6 months post activation
Speech perception in quiet
6 months post activation
Speech Spatial and Qualities of Hearing Scale (SSQ)
6 months post activation
Datalogging
6 months post activation
Study Arms (2)
Anatomy-Based Electrode Selection
EXPERIMENTALFor individuals in the anatomy-based electrode (ABE) group, magnetic resolution imaging (MRI) or computed tomography (CT) scans will be evaluated by MED-EL Canada employees. Based on these results, an appropriate electrode array will be selected.
Standard of Care Electrode Selection
ACTIVE COMPARATORThe comparison in this study will be to current standard of care, which is to select a single electrode length for most patients, in this case the FLEX28 electrode, which is 28 mm long.
Interventions
Use of pre-operative imaging to select the appropriate length electrode vs standard of care
Use of standard of care electrode which is the FLEX 28 electrode
Eligibility Criteria
You may qualify if:
- years of age or older at the time of implantation
- Unilateral severe to profound sensorineural hearing loss, as defined by a pure-tone average (500, 1000, 2000, and 4000 Hz) of 70 dB HL or greater
- Normal hearing mild hearing loss in the non-implanted ear, as defined by a pure-tone average (500, 1000, 2000, and 4000 Hz) of 40 dB or less
- Deemed an appropriate candidate by the investigator
- Fluent in English
You may not qualify if:
- Duration of profound hearing loss of 10 years or more
- Sudden onset of hearing loss within six months of implantation
- Evidence of non-functional cochlear nerve using appropriate imaging modality to be determined by the investigator
- Other retrocochlear hearing loss
- Evidence of severe cochlear malformation (i.e., common cavity or ossification)
- External or middle ear infection
- Suspected developmental or cognitive concern
- Other medical contraindication for surgery or anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nova Scotia Health Authoritylead
- Med-El Corporationcollaborator
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2023
First Posted
January 3, 2024
Study Start
April 1, 2024
Primary Completion
October 1, 2025
Study Completion
December 1, 2025
Last Updated
January 3, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share